Glucocorticoid Receptor Binding to a Specific DNA Sequence Is Required for Hormone-Dependent Repression of Pro-Opiomelanocortin Gene Transcription

LITERATURE CITED

• Adler, S., M. L. Waterman, X. He, and M. G. Rosenfeld. 1988. Steroid receptor-mediated inhibition of rat prolactin gene expression does not require the receptor DNA-binding domain. Cell 52:685–695.
   PubMed Web of Science ®Google Scholar
• Affolter, H. U., and T. Reisine. 1985. Corticotropin releasing factor increases pro-opiomelanocortin messenger RNA in mouse anterior pituitary tumor cells. J. Biol. Chem. 260:15477–15481.
   PubMedGoogle Scholar
• Akerblom, I. E., E. P. Slater, M. Beato, J. D. Baxter, and P. L. Mellon. 1988. Negative regulation by glucocorticoids through intereference with a cAMP responsive enhancer. Science 241:992–994.
   PubMedGoogle Scholar
• Barberis, A., G. Superti-Furga, and M. Busslinger. 1987. Mutually exclusive interaction of the CCAAT-binding factor and of a displacement protein with overlapping sequences of a histone gene promoter. Cell 50:347–359.
   PubMed Web of Science ®Google Scholar
• Beato, M.. 1989. Gene regulation by steroid hormones. Cell 56:335–344.
   PubMed Web of Science ®Google Scholar
• Becker, P. B., B. Gloss, W. Schmid, U. Strahle, and G. Schutz. 1986. In vivo protein-DNA interactions in a glucocorticoid response element require the presence of the hormone. Nature (London) 324:686–688.
   PubMed Web of Science ®Google Scholar
• Birnberg, N. C., J. C. Lissitzky, M. Hinman, and E. Herbert. 1983. Glucocorticoids regulate pro-opiomelanocortin gene expression in vivo at the levels of transcription and secretion. Proc. Natl. Acad. Sci. USA 80:6982–6986.
   PubMedGoogle Scholar
• Brent, R.. 1985. Repression of transcription in yeast. Cell 42:3–4.
   PubMed Web of Science ®Google Scholar
• Buetti, E., and B. Kiihnel. 1986. Distinct sequence elements involved in the glucocorticoid regulation of the mouse mammary tumor virus promoter identified by linker scanning muta- genesis. J. Mol. Biol. 190:379–389.
   PubMed Web of Science ®Google Scholar
• Busso, N., M. Collart, J.-D. Vassalli, and D. Belin. 1987. Antagonist effect of RU 486 on transcription of glucocorticoid- regulated genes. Exp. Cell Res. 173:425–430.
   PubMed Web of Science ®Google Scholar
• Camper, S. A., Y. A. S. Yao, and F. M. Rottman. 1985. Hormonal regulation of the bovine prolactin promoter in rat pituitary tumor cells. J. Biol. Chem. 260:12246–12251.
   PubMedGoogle Scholar
• Chandler, V. L., B. A. Maier, and K. R. Yamamoto. 1983. DNA sequences bound specifically by glucocorticoid receptor in vitro render a heterologous promoter hormone responsive in vivo. Cell 33:489–499.
   PubMed Web of Science ®Google Scholar
• Charron, J., and J. Drouin. 1986. Glucocorticoid inhibition of transcription from episomal pro-opiomelanocortin gene promoter. Proc. Natl. Acad. Sci. USA 83:8903–8907.
   PubMed Web of Science ®Google Scholar
• Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299.
   PubMed Web of Science ®Google Scholar
• Cordingley, M. C., A. T. Reigel, and G. L. Hager. 1987. Steroid-dependent interaction of transcription factors with the inducible promoter of mouse mammary tumor virus in vivo. Cell 48:261–270.
   PubMed Web of Science ®Google Scholar
• Drouin, J., M. Chamberland, J. Charron, L. Jeannotte, and M. Nemer. 1985. Structure of the rat pro-opiomelanocortin (POMC) gene. FEBS Lett. 193:54–58.
   PubMedGoogle Scholar
• Drouin, J., J. Charron, L. Jeannotte, M. Nemer, R. K. Plante, and O. Wrange. 1987. Pro-opiomelanocortin gene: a model for negative regulation of transcription by glucocorticoids. J. Cell Biochem. 35:293–304.
   PubMedGoogle Scholar
• Drouin, J., and H. M. Goodman. 1980. Most of the coding region of rat ACTH β-LPH precursor gene lacks intervening sequences. Nature (London) 288:610–613.
   PubMed Web of Science ®Google Scholar
• Drouin, J., and F. Labrie. 1976. Selective effect of androgens on LH and FSH release in anterior pituitary cells in culture. Endocrinology 98:1528–1534.
   PubMedGoogle Scholar
• Eberwine, J. H., and J. L. Roberts. 1984. Glucocorticoid regulation of pro-opiomelanocortin gene transcription in the rat pituitary. J. Biol. Chem. 259:2166–2170.
   PubMedGoogle Scholar
• Fremeau, R. T., Jr., J. R. Lundblad, D. B. Pritchett, J. N. Wilcox, and J. L. Roberts. 1986. Regulation of pro-opiomelanocortin gene transcription in individual cell nuclei. Science 234:1265–1269.
   PubMedGoogle Scholar
• Frisch, S. M., and H. E. Ruley. 1987. Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J. Biol. Chem. 262:16300–16304.
   PubMed Web of Science ®Google Scholar
• Gagner, J.-P., and J. Drouin. 1985. Opposite regulation of pro-opiomelanocortin gene transcription by glucocorticoids and CRH. Mol. Cell. Endocrinol. 40:25–32.
   PubMed Web of Science ®Google Scholar
• Gagner, J.-P., and J. Drouin. 1987. Tissue-specific regulation of pituitary pro-opiomelanocortin gene transcription by corticotropin-releasing hormone, 3′,5′-cyclic adenosine monophosphate, and glucocorticoids. Mol. Endocrinol. 1:677–682.
   PubMedGoogle Scholar
• Galas, D. J., and A. Schmitz. 1978. DNase footprinting: a simple method for detection of protein-DNA binding specificity. Nucleic Acids Res. 5:3157–3170.
   PubMed Web of Science ®Google Scholar
• Giguere, V., S. M. Hollenberg, M. G. Rosenfeld, and R. M. Evans. 1986. Functional domains of the human glucocorticoid receptor. Cell 46:645–652.
   PubMed Web of Science ®Google Scholar
• Glass, C. K., J. M. Holloway, O. V. Devary, and M. G. Rosenfeld. 1988. The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements. Cell 54:313–323.
   PubMed Web of Science ®Google Scholar
• Godowski, P. J., S. Rusconi, R. Miesfeld, and K. R. Yamamoto. 1987. Glucocorticoid receptor mutants that are constitutive activators of transcriptional enhancement. Nature (London) 325:365–368.
   PubMed Web of Science ®Google Scholar
• Goodbourn, S., H. Burstein, and T. Maniatis. 1986. The human β-interferon gene enhancer is under negative control. Cell 45:601–610.
   PubMed Web of Science ®Google Scholar
• Guertin, M., P. Baril, J. Bartkowiak, A. Anderson, and L. Bdanger. 1983. Rapid suppression of α1-fetoprotein gene transcription by dexamethasone in developing rat liver. Biochemis try 22:4296–4302.
   PubMedGoogle Scholar
• Guertin, M., H. Larue, D. Bernier, O. Wrange, M. Chevrette, M.-C. Gingras, and L. Belanger. 1988. Enhancer and promoter elements directing activation and glucocorticoid repression of the α1-fetoprotein gene in hepatocytes. Mol. Cell. Biol. 8:1398–1407.
   PubMed Web of Science ®Google Scholar
• Hollenberg, S. M., V. Giguere, P. Segui, and R. M. Evans. 1987. Colocalization of DNA-binding and transcriptional activation functions in the human glucocorticoid receptor. Cell 49:39–46.
   PubMed Web of Science ®Google Scholar
• Huang, A. L., M. C. Ostrowski, D. Berard, and G. L. Hager. 1981. Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus. Cell 27:245–255.
   PubMed Web of Science ®Google Scholar
• Hwung, Y. P., L. H. Wang, S. Y. Tsai, and M. J. Tsai. 1988. Differential binding of the chicken ovalbumin upstream promoter (COUP) transcription factor to two different promoters. J. Biol. Chem. 263:13470–13474.
   PubMed Web of Science ®Google Scholar
• Israel, A., and S. N. Cohen. 1985. Hormonally-mediated negative regulation of human pro-opiomelanocortin gene expression after transfection into mouse L cells. Mol. Cell. Biol. 5:2443–2453.
   PubMed Web of Science ®Google Scholar
• Jeannotte, L., M. A. Trifiro, R. K. Plante, M. Chamberland, and J. Drouin. 1987. Tissue-specific activity of the pro-opiomelanocortin gene promoter. Mol. Cell. Biol. 7:4058–4064.
   PubMedGoogle Scholar
• Keegan, L., G. Gill, and M. Ptashne. 1986. Separation of DNA binding from the transcription-activating function of a eukaryotic regulatory protein. Science 231:699–704.
   PubMed Web of Science ®Google Scholar
• Lee, F., R. Mulligan, P. Berg, and G. Ringold. 1981. Glucocorticoids regulate expression of dihydrofolate reductase cDNA in mouse mammary tumor virus chimaeric plasmids. Nature (London) 294:228–232.
   PubMed Web of Science ®Google Scholar
• Majors, J., and H. E. Varmus. 1983. A small region of the mouse mammary tumor virus long terminal repeat confers glucocorticoid hormone regulation on a linked heterologous gene. Proc. Natl. Acad. Sci. USA 80:5866–5870.
   PubMedGoogle Scholar
• Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Melton, D. A., P. A. Krieg, M. R. Rebagliati, T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vivo synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:7035–7056.
   PubMed Web of Science ®Google Scholar
• Miksicek, R., A. Heber, W. Schmid, U. Danesch, G. Posseckert, M. Beato, and G. Schutz. 1986. Glucocorticoid responsiveness of the transcriptional enhancer of Moloney murine sarcoma virus. Cell 46:283–290.
   PubMedGoogle Scholar
• Moguilewsky, M., and D. Philibert. 1984. RU-38486: potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation. J. Steroid Biochem. 20:271–276.
   PubMedGoogle Scholar
• Nakamaye, K. L., and F. Eckstein. 1986. Inhibition of restriction endonuclease Nci I cleavage by phosphorothioate groups and its application to oligonucleotide-directed mutagenesis. Nucleic Acids Res. 14:9679–9698.
   PubMed Web of Science ®Google Scholar
• Nakamura, M., S. Nakanishi, S. Sueoka, H. Imura, and S. Numa. 1978. Effects of steroid hormones on the level of corticotropin messenger RNA activity in cultured mouse-pituitary- tumor cells. Eur. J. Biochem. 86:61–66.
   PubMedGoogle Scholar
• Ogata, R. T., and W. Gilbert. 1978. An amino-terminal fragment of lac repressor binds specifically to lac operator. Proc. Natl. Acad. Sci. USA 75:5851–5854.
   PubMedGoogle Scholar
• Oro, A. E., S. M. Hollenbert, and R. M. Evans. 1988. Transcriptional inhibition by a glucocorticoid receptor-β-galactosidase fusion protein. Cell 55:1109–1114.
   PubMedGoogle Scholar
• Payvar, F. P., D. De Franco, G. L. Firestone, B. Edgar, O. Wrange, S. Okret, J.-A. Gustafsson, and K. R. Yamamoto. 1983. Sequence-specific binding of glucocorticoid receptor to MTV DNA at sites within and upstream of the transcribed region. Cell 35:381–392.
   PubMed Web of Science ®Google Scholar
• Perlmann, T., and O. Wrange. 1988. Specific glucocorticoid receptor binding to DNA reconstituted in a nucleosome. EMBO J. 7:3073–3079.
   PubMedGoogle Scholar
• Pfeifer, K., T. Prezant, and L. Guarente. 1987. Yeast HAP1 activator binds to two upstream activation sites of different sequence. Cell 49:19–27.
   PubMedGoogle Scholar
• Ponta, H., N. Kennedy, P. Skroch, N. E. Hynes, and B. Groner. 1985. Hormonal response region in the mouse mammary tumor virus long terminal repeat can be dissociated from the proviral promoter and has enhancer properties. Proc. Natl. Acad. Sci. USA 82:1020–1024.
   PubMedGoogle Scholar
• Potter, H., L. Weir, and P. Leder. 1984. Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc. Natl. Acad. Sci. USA 81:7161–7165.
   PubMed Web of Science ®Google Scholar
• Ptashne, M.. 1986. A genetic switch. Cell Press & Blackwell Scientific Publications, Cambridge, Mass.
   Google Scholar
• Renkawitz, R., G. Schutz, D. von der Ahe, and M. Beato. 1984. Sequences in the promoter region of the chicken lysozyme gene required for steroid regulation and receptor binding. Cell 37:503–510.
   PubMed Web of Science ®Google Scholar
• Reznikoff, W. S., D. Siegele, D. W. Cowing, and C. A. Gross. 1985. The regulation of transcription initiation in bacteria. Annu. Rev. Genet. 19:355–387.
   PubMed Web of Science ®Google Scholar
• Richard-Foy, H., and G. L. Hager. 1987. Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter. EMBO J. 6:2321–2328.
   PubMed Web of Science ®Google Scholar
• Roberts, J. L., M. L. Budarf, J. D. Baxter, and E. Herbert. 1979. Selective reduction of pro-adrenocorticotropin/endorphin proteins and messenger ribonucleic acid activity in mouse pituitary tumor cells by glucocorticoids. Biochemistry 18:4907–4915.
   PubMedGoogle Scholar
• Sakai, D. D., S. Helms, J. Carlstedt-Duke, J.-A. Gustafsson, F. M. Rottman, and K. R. Yamamoto. 1988. Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene. Genes Dev. 2:1144–1154.
   PubMed Web of Science ®Google Scholar
• Scheidereit, C., and M. Beato. 1984. Contacts between hormone receptor and DNA double helix within a glucocorticoid regulatory elements by mouse mammary tumor virus. Proc. Natl. Acad. Sci. USA 81:3029–3033.
   PubMedGoogle Scholar
• Scheidereit, C., S. Geisse, H. M. Westphal, and M. Beato. 1983. The glucocorticoid receptor binds to defined nucleotide sequences near the promoter of mouse mammary tumor virus. Nature (London) 304:749–752.
   PubMed Web of Science ®Google Scholar
• Schiile, R., M. Muller, H. Otsuka-Murakami, and R. Renkawitz. 1988. Cooperativity of the glucocorticoid receptor and the CACCC-box binding factor. Nature (London) 332:87–92.
   PubMedGoogle Scholar
• Strahle, U., G. Klock, and G. Schutz. 1987. A DNA sequence of 15 base pairs is sufficient to mediate both glucocorticoid and progesterone induction of gene expression. Proc. Natl. Acad. Sci. USA 84:7871–7875.
   PubMed Web of Science ®Google Scholar
• Tremblay, Y., I. Tretjakoff, A. Peterson, T. Antakly, C. X. Zhang, and J. Drouin. 1988. Pituitary-specific expression and glucocorticoid regulation of a pro-opiomelanocortin (POMC) fusion gene in transgenic mice. Proc. Natl. Acad. Sci. USA 85:8890–8894.
   PubMedGoogle Scholar
• von der Ahe, D., S. Janich, C. Scheidereit, R. Renkawitz, G. Schutz, and M. Beato. 1985. Glucocorticoid and progesterone receptors bind to the same site in two hormonally regulated promoters. Nature (London) 313:706–709.
   PubMedGoogle Scholar
• Webster, N. J. G., S. Green, J. R. Jin, and P. Chambon. 1988. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function. Cell 54:199–207.
   PubMed Web of Science ®Google Scholar
• Weiner, F. R., M. J. Czaja, D. M. Jefferson, M.-A. Giambrone, R. Tur-Kaspa, L. M. Reid, and M. A. Zern. 1987. The effects of dexamethasone on in vitro collagen gene expression. J. Biol. Chem. 252:6955–6958.
   Google Scholar
• Wrange, O., J. Carlstedt-Duke, and J. A. Gustafsson. 1986. Stoichiometric analysis of the specific interaction of the glucocorticoid receptor with DNA. J. Biol. Chem. 261:11770–11778.
   PubMedGoogle Scholar
• Wrange, O., S. Okret, M. Radojcic, J. Carlstedt-Duke, and J.-A. Gustafsson. 1984. Characterization of the purified glucocorticoid receptor from rat liver cytosol. J. Biol. Chem. 259:4534–4541.
   PubMed Web of Science ®Google Scholar
• Yamamoto, K. R.. 1985. Steroid receptor regulated transcription of specific genes and gene networks. Annu. Rev. Genet. 19:209–252.
   PubMed Web of Science ®Google Scholar